Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Retained Earnings: 2009-2024

Historic Retained Earnings for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $12.0 billion.

  • Fresenius Medical Care AG's Retained Earnings rose 13.69% to $13.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 billion, marking a year-over-year increase of 13.69%. This contributed to the annual value of $12.0 billion for FY2024, which is 1.90% up from last year.
  • Per Fresenius Medical Care AG's latest filing, its Retained Earnings stood at $12.0 billion for FY2024, which was up 1.90% from $11.8 billion recorded in FY2023.
  • Fresenius Medical Care AG's 5-year Retained Earnings high stood at $12.8 billion for FY2021, and its period low was $11.3 billion during FY2022.
  • Over the past 3 years, Fresenius Medical Care AG's median Retained Earnings value was $11.8 billion (recorded in 2023), while the average stood at $11.7 billion.
  • Per our database at Business Quant, Fresenius Medical Care AG's Retained Earnings increased by 10.58% in 2020 and then dropped by 11.88% in 2022.
  • Over the past 5 years, Fresenius Medical Care AG's Retained Earnings (MRY) stood at $11.7 billion in 2020, then grew by 9.42% to $12.8 billion in 2021, then fell by 11.88% to $11.3 billion in 2022, then grew by 4.65% to $11.8 billion in 2023, then grew by 1.90% to $12.0 billion in 2024.
  • Its Retained Earnings stands at $12.0 billion for FY2024, versus $11.8 billion for FY2023 and $11.3 billion for FY2022.